2011
DOI: 10.1159/000327889
|View full text |Cite
|
Sign up to set email alerts
|

Minimally Invasive Biopsy Methods – Diagnostics or Therapy? Personal Opinion and Review of the Literature

Abstract: This article provides an overview of different minimally invasive biopsy (MIB) methods for preoperative assessment of suspicious and indeterminate breast lesions. Accuracy depends on the choice of method and on lesion characteristics. An additional aspect deals with the question whether or not MIB is a suitable therapeutic approach in selected lesions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 46 publications
0
4
0
Order By: Relevance
“…The sample obtained by VAB is larger than that obtained by core needle biopsy 10 and thus provides more a accurate pathological diagnosis. Penco et al.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The sample obtained by VAB is larger than that obtained by core needle biopsy 10 and thus provides more a accurate pathological diagnosis. Penco et al.…”
Section: Discussionmentioning
confidence: 99%
“…VAB is an accurate diagnostic method for breast microcalcifications and can avoid unnecessary surgery, making it the preferred technique for guiding biopsies. The sample obtained by VAB is larger than that obtained by core needle biopsy 10 and thus provides more a accurate pathological diagnosis. Penco et al.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, in many countries there is a clear trend that breast tumors tend to be smaller when diagnosed. Focus of this issue of Breast Care are new developments in breast imaging, reported and discussed by highly experienced specialists [1][2][3][4][5].Another reason why breast cancer is turning into a curable disease is the consequent and well standardized treatment of early breast cancer with regard to adjuvant therapy. According to the EBCTCG overview [6], even with traditional adjuvant therapies, i.e.…”
mentioning
confidence: 99%